Annual Working Capital
$3.27 M
+$3.08 M+1638.83%
01 June 2024
Summary:
Kintara Therapeutics annual working capital is currently $3.27 million, with the most recent change of +$3.08 million (+1638.83%) on 01 June 2024. During the last 3 years, it has fallen by -$5.74 million (-63.73%).KTRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$3.27 M
-$2.15 M-39.62%
01 June 2024
Summary:
Kintara Therapeutics quarterly working capital is currently $3.27 million, with the most recent change of -$2.15 million (-39.62%) on 01 June 2024. Over the past year, it has increased by +$5.82 million (+228.05%).KTRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1638.8% | +228.1% |
| 3 y3 years | -63.7% | -80.9% |
| 5 y5 years | +67.2% | -53.4% |
KTRA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -64.7% | -84.1% |
Kintara Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $3.27 M(+1638.8%) | $3.27 M(-39.6%) |
| Mar 2024 | - | $5.41 M(-891.5%) |
| Dec 2023 | - | -$684.00 K(-73.2%) |
| Sept 2023 | - | -$2.55 M(-1458.0%) |
| June 2023 | $188.00 K(-98.0%) | $188.00 K(-94.2%) |
| Mar 2023 | - | $3.23 M(-45.7%) |
| Dec 2022 | - | $5.94 M(+28.0%) |
| Sept 2022 | - | $4.64 M(-49.9%) |
| June 2022 | $9.27 M(+2.8%) | $9.27 M(+35.2%) |
| Mar 2022 | - | $6.85 M(-40.7%) |
| Dec 2021 | - | $11.56 M(-32.4%) |
| Sept 2021 | - | $17.11 M(+89.8%) |
| June 2021 | $9.01 M(+5021.0%) | $9.01 M(-35.9%) |
| Mar 2021 | - | $14.05 M(-6.2%) |
| Dec 2020 | - | $14.99 M(-27.1%) |
| Sept 2020 | - | $20.57 M(>+9900.0%) |
| June 2020 | $176.00 K(-91.0%) | $176.00 K(-95.3%) |
| Mar 2020 | - | $3.72 M(-32.1%) |
| Dec 2019 | - | $5.47 M(-22.0%) |
| Sept 2019 | - | $7.02 M(+258.8%) |
| June 2019 | $1.96 M(-63.8%) | $1.96 M(+57.1%) |
| Mar 2019 | - | $1.24 M(-54.8%) |
| Dec 2018 | - | $2.75 M(-24.6%) |
| Sept 2018 | - | $3.65 M(-32.5%) |
| June 2018 | $5.41 M(-17.6%) | $5.41 M(-29.1%) |
| Mar 2018 | - | $7.63 M(-23.4%) |
| Dec 2017 | - | $9.96 M(-22.7%) |
| Sept 2017 | - | $12.89 M(+96.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | $6.57 M(+15.4%) | $6.57 M(+406.2%) |
| Mar 2017 | - | $1.30 M(-54.4%) |
| Dec 2016 | - | $2.85 M(-37.2%) |
| Sept 2016 | - | $4.53 M(-20.4%) |
| June 2016 | $5.69 M(+230.5%) | $5.69 M(+1195.5%) |
| Mar 2016 | - | $439.40 K(-72.6%) |
| Dec 2015 | - | $1.61 M(-38.7%) |
| Sept 2015 | - | $2.62 M(+52.1%) |
| June 2015 | $1.72 M(-63.4%) | $1.72 M(-40.3%) |
| Mar 2015 | - | $2.88 M(-24.8%) |
| Dec 2014 | - | $3.83 M(-7.9%) |
| Sept 2014 | - | $4.16 M(+25.6%) |
| June 2014 | $4.70 M(+15.6%) | - |
| Mar 2014 | - | $3.31 M(-18.6%) |
| Dec 2013 | $4.07 M(<-9900.0%) | $4.07 M(-18.0%) |
| Sept 2013 | - | $4.97 M(-15.2%) |
| June 2013 | - | $5.85 M(-14.2%) |
| Mar 2013 | - | $6.82 M(<-9900.0%) |
| Dec 2012 | - | -$15.60 K(+25.8%) |
| Sept 2012 | - | -$12.40 K(+51.2%) |
| June 2012 | - | -$8200.00(+13.9%) |
| June 2012 | -$8200.00(-176.6%) | - |
| Mar 2012 | - | -$7200.00(+75.6%) |
| Dec 2011 | - | -$4100.00(-160.3%) |
| Sept 2011 | - | $6800.00(-36.4%) |
| June 2011 | $10.70 K(-75.6%) | $10.70 K(-38.9%) |
| Mar 2011 | - | $17.50 K(-18.2%) |
| Dec 2010 | - | $21.40 K(-51.3%) |
| June 2010 | $43.90 K | $43.90 K |
FAQ
- What is Kintara Therapeutics annual working capital?
- What is the all time high annual working capital for Kintara Therapeutics?
- What is Kintara Therapeutics annual working capital year-on-year change?
- What is Kintara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly working capital year-on-year change?
What is Kintara Therapeutics annual working capital?
The current annual working capital of KTRA is $3.27 M
What is the all time high annual working capital for Kintara Therapeutics?
Kintara Therapeutics all-time high annual working capital is $9.27 M
What is Kintara Therapeutics annual working capital year-on-year change?
Over the past year, KTRA annual working capital has changed by +$3.08 M (+1638.83%)
What is Kintara Therapeutics quarterly working capital?
The current quarterly working capital of KTRA is $3.27 M
What is the all time high quarterly working capital for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly working capital is $20.57 M
What is Kintara Therapeutics quarterly working capital year-on-year change?
Over the past year, KTRA quarterly working capital has changed by +$5.82 M (+228.05%)